Personalized Intervention to Improve Medication Adherence for Persons with Multiple Sclerosis

References

• Reich D, Lucchinetti C, Calabresi PA, Longo DL. Multiple Sclerosis. N Engl J Med. 2018;378:169–180. doi:10.1056/NEJMra1401483
   PubMed Web of Science ®Google Scholar
• Yermakov S, Davis M, Calnan M, et al. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis. J Med Econ. 2015;18(9):711–720. doi:10.3111/13696998.2015.1044276
   PubMed Web of Science ®Google Scholar
• Hao J, Pitcavage J, Jones JB, Hoegerl C, Graham J. Measuring adherence and outcomes in the treatment of patients with multiple sclerosis. J Am Osteopath Assoc. 2017;117(12):737. doi:10.7556/jaoa.2017.145
   PubMed Web of Science ®Google Scholar
• Burks J, Marshall TS, Ye X. Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis. Clin Outcomes Res. 2017;9:251–260. doi:10.7224/1537-2073.2022-018
   PubMed Web of Science ®Google Scholar
• Lizàn L, Comellas M, Paz S, Poveda JL, Meletiche D, Polanco C. Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature. Patient Prefer Adherence. 2014;8:1653–1664. doi:10.1586/ern.11.161
   PubMed Web of Science ®Google Scholar
• Schoor R, Bruce A, Bruce J, et al. Reasons for nonadherence and response to treatment in an adherence intervention trial for relapsing–remitting multiple sclerosis patients. J Clin Psychol. 2018;75(3):380–391. doi:10.2147/PPA.S67253
   PubMed Web of Science ®Google Scholar
• Bruce J, Lynch SG. Multiple sclerosis: MS treatment adherence-how to keep patients on medication? Nat Rev Neurol. 2011;7(8):421–422. doi:10.1038/nrneurol.2011.106
   PubMed Web of Science ®Google Scholar
• Haase R, Kullmann JS, Ziemssen T. Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey. Ther Adv Neurol Disord. 2016;9(4):250–263. doi:10.1177/1756285616634247
   PubMed Web of Science ®Google Scholar
• Evans C, Marrie RA, Yao S, et al. Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study. BMJ Open. 2021;11(2):1–13. doi:10.1136/bmjopen-2020-043930
   Web of Science ®Google Scholar
• Nicholas JA, Edwards NC, Edwards RA, Dellarole A, Grosso M, Phillips AL. Real-world adherence to, and persistence with, once- And twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol. 2020;20(1):1–15. doi:10.1186/s12883-020-01830-0
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Adherence to Long-Term Therapies. Evidence for Action; 2003.
   Google Scholar
• Marangi A, Farina G, Vicenzi V, et al. Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy. Mult Scler Relat Disord. 2020;41:102004. doi:10.1016/j.msard.2020.102004
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Adherence to Long-Term Therapies: Evidence for Action.; 2003. doi:10.1016/j.neuron.2012.03.011
   Google Scholar
• Neter E, Glass-marmor L, Wolkowitz A, Lavi I, Miller A. Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis. BMC Neurol. 2021;21:1–9. doi:10.1186/s12883-020-02014-6
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008
   PubMed Web of Science ®Google Scholar
• Conn VS, Enriquez M, Ruppar TM, Chan KC. Meta-analyses of theory use in medication adherence intervention research. Am J Heal Behav. 2016;40(2):155–171. doi:10.5993/AJHB.40.2.1
   PubMed Web of Science ®Google Scholar
• Bruce J, Bruce A, Lynch S, et al. A pilot study to improve adherence among MS patients who discontinue treatment against medical advice. J Behav Med. 2016;39(2):276–287. doi:10.1007/s10865-015-9694-6
   PubMed Web of Science ®Google Scholar
• Berger BA, Liang H, Hudmon KS. Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. J Am Pharm Assoc. 2005;45(4):466–472. doi:10.1331/1544345054475469
   Google Scholar
• Schreiber K, Kant M, Pfleger C, et al. High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study. Patient Prefer Adherence. 2018;12:1139–1150. doi:10.2147/PPA.S166278
   PubMed Web of Science ®Google Scholar
• Roche J, McCarry Y, Mellors K. Enhanced patient support services improve patient persistence with multiple sclerosis treatment. Patient Prefer Adherence. 2014;8:805–811. doi:10.2147/PPA.S59496
   PubMed Web of Science ®Google Scholar
• Golan D, Sagiv S, Glass-Marmor L, Miller A. Mobile phone-based e-diary for assessment and enhancement of medications adherence among patients with multiple sclerosis. Mult Scler J Exp Transl Clin. 2020;6(3):205521732093930. doi:10.1177/2055217320939309
   Google Scholar
• Turner AP, Sloan AP, Kivlahan DR, Haselkorn JK. Telephone counseling and home telehealth monitoring to improve medication adherence: results of a pilot trial among individuals with multiple sclerosis. Rehabil Psychol. 2014;59(2):136–146. doi:10.1037/a0036322
   PubMed Web of Science ®Google Scholar
• Moeckli J, Stewart KR, Ono S, et al. Mixed-Methods study of uptake of the extension for community health outcomes (ECHO) Telemedicine Model for Rural Veterans With HIV. J Rural Health. 2016. doi:10.1111/jrh.12200
   PubMed Web of Science ®Google Scholar
• Berger-Achituv S, Shohat T, Romano-Zelekha O, et al. Widespread use of soy-based formula without clinical indications. J Pediatr Gastroenterol Nutr. 2005;41(5):660–666. doi:10.1097/01.mpg.0000181855.77488.bf
   PubMed Web of Science ®Google Scholar
• Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med. 2016;31(8):929–940. doi:10.1007/s11606-016-3685-3
   PubMed Web of Science ®Google Scholar
• Neter E, Miller A. Using an intervention mapping approach to improve adherence to Disease-Modifying Treatment in Multiple Sclerosis. Int J Mult Scler Care. 2023;25:206–213. doi:10.7224/1537-2073.2022-018
   Google Scholar
• Kleppe M, Lacroix J, Ham J, Midden C. The development of the ProMAS: A probabilistic medication adherence scale. Patient Prefer Adherence. 2015;9:355–367. doi:10.2147/Ppa.S76749
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452. doi:10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Whoqol Group T, WHOQOL Group. the World Health Organization Quality of Life Assessment (Whoqol): development and General Psychometric Properties. Soc Sci Med. 1998;46(12):1569–1585. doi:10.1016/S0277-9536(98)00009-4
   PubMed Web of Science ®Google Scholar
• Neter E, Wolkowitz A, Glass-Marmor L, et al. Multiple modality approach to assess adherence to medications across time in Multiple Sclerosis. Mult Scler Relat Disord. 2020;40:101951. doi:10.1016/j.msard.2020.101951
   PubMed Web of Science ®Google Scholar
• Sesel AL, Sharpe L, Naismith SL. Efficacy of psychosocial interventions for people with Multiple Sclerosis: a meta-analysis of specific treatment effects. Psychother Psych. 2018;87(2):105–111. doi:10.1159/000486806
   PubMed Web of Science ®Google Scholar
• Kidd T, Carey N, Mold F, et al. A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life. PLoS One. 2017;12(10):1–16. doi:10.1371/journal.pone.0185931
   Web of Science ®Google Scholar
• Huh J, Cerrada CJ, Dzubur E, Dunton GF, Spruijt-Metz D, Leventhal AM. Effect of a mobile just-in-time implementation intention intervention on momentary smoking lapses in smoking cessation attempts among Asian American young adults. Transl Behav Med. 2021;11(1):216–225. doi:10.1093/tbm/ibz183
   PubMed Web of Science ®Google Scholar
• Lejbkowicz I, Caspi O, Miller A. Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis. Expert Rev Neurother. 2012;12(3):343–352. doi:10.5993/AJHB.40.2.1
   PubMed Web of Science ®Google Scholar
• Inauen J, Bierbauer W, Lüscher J, et al. Assessing adherence to multiple medications and in daily life among patients with multimorbidity. Psychol Health. 2017:1–16. doi:10.1080/08870446.2016.1275632
   PubMed Web of Science ®Google Scholar